Skip to main content

Table 1

From: Infectious adverse effects during treatment with IL-1 inhibitors in patients with systemic juvenile idiopathic arthritis and autoinflammatory diseases

 

SJIA: 28 patients

AD: 11 patients

Canakinumab

1 pneumonia

1 Herpes Zoster

  

1 Soft tissue infection

  

1 Recurrent low urinary tract infection

Anakinra

4 pneumonia

1 pneumonia

 

1 HPV infection

1 sepsis

 

1 severe VEB infection

1 severe herpetic stomatitis

  

1 Recurrent low urinary tract infection

  

2 oropharingeal candidiasis